Meta Platforms
META
Ecopetrol
EC
MARA Holdings
MARA
Oracle
ORCL
Salesforce
CRM
US Stock MarketDetailed Quotes
OGN Organon & Co
- 16.410
- +0.540+3.40%
Close Jan 23 16:00 ET
- 16.290
- -0.120-0.73%
Post 16:12 ET
4.23BMarket Cap3.25P/E (TTM)
16.430High15.820Low2.08MVolume15.840Open15.870Pre Close33.72MTurnover0.81%Turnover Ratio4.11P/E (Static)257.54MShares22.69852wk High8.57P/B4.21BFloat Cap13.87052wk Low1.12Dividend TTM256.70MShs Float33.964Historical High6.83%Div YieldTTM3.84%Amplitude10.199Historical Low16.193Avg Price1Lot Size
About Organon & Co Company
Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.
Company Profile
SymbolOGN
Company NameOrganon & Co
Listing DateMay 14, 2021
Founded2020
CEOMr. Kevin Ali
MarketNYSE
Employees10000
Fiscal Year Ends12-31
Address30 Hudson Street,33rd floor
CityJersey City
ProvinceNew Jersey
CountryUnited States of America
Zip Code07302
Phone1-551-430-6900
Websitehttp://www.organon.com
Company Executives
- Name
- Position
- Salary
- Kevin Ali
- Chief Executive Officer and Director
- 14.83M
- Matthew M. Walsh
- Executive Vice President and Chief Financial Officer
- 5.21M
- Dr. Juan Camilo Arjona Ferreira, M.D.
- Executive Vice President, Head of Research and Development and Chief Medical Officer
- --
- Rachel A. Stahler
- Executive Vice President and Chief Information Officer
- --
- Aaron Falcione
- Executive Vice President and Chief Human Resources Officer
- --
- Vittorio Nisita
- Executive Vice President and Head of Global Business Services
- --
- Kirke Weaver
- Executive Vice President, General Counsel and Corporate Secretary
- 3.19M
- Joseph T. Morrissey, Jr
- Executive Vice President and Head of Manufacturing and Supply
- 3.74M
- Carrie S. Cox
- Chairman of the Board
- 450.00K
- Shalini Sharp
- Independent Director
- 345.00K
- Grace Puma Whiteford
- Independent Director
- 320.00K
- Robert A. Essner
- Independent Director
- 335.00K
- Dr. Phillip Ozuah, M.D.,PhD
- Independent Director
- 320.00K
- Dr. Helene D. Gayle, M.D.
- Independent Director
- 320.00K
- Rochelle B. Lazarus
- Independent Director
- 320.00K
- Dr. Alan Ezekowitz, D.Phil.,MB.Ch.B.
- Independent Director
- 330.00K
- Deborah R. Leone
- Independent Director
- 330.00K
- Cynthia M. Patton
- Independent Director
- 330.00K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.